Intermediateclinical correlationsArticle
Eczema: When the Skin Barrier Fails
Learning objectives
- Describe the skin barrier's brick-and-mortar structure.
- Explain filaggrin's role and the effect of its loss.
- Explain transepidermal water loss in eczema.
- Describe the Th2 immune skew of atopic dermatitis.
- Explain the itch-scratch cycle mechanistically.
- Distinguish atopic dermatitis from contact dermatitis.
The barrier: bricks, mortar, and sealant
The skin's outermost layer, the stratum corneum, is often described as brick and mortar: the 'bricks' are flattened, dead keratinocytes (corneocytes) packed with the protein keratin, and the 'mortar' is a precise mixture of ceramides, cholesterol, and fatty acids filling the spaces between them. This structure is the body's primary barrier — it keeps water in and microbes, allergens, and irritants out. Its integrity depends on filaggrin, a protein that bundles keratin fibers inside corneocytes and later breaks down into the natural moisturizing factors (amino acids and derivatives) that hydrate the stratum corneum and maintain its acidic pH. When this system works, the skin is a sealed wall; when it fails, everything that follows in eczema becomes possible.
Filaggrin loss: the genetic crack in the wall
Loss-of-function mutations in the filaggrin gene (FLG) are the strongest known genetic risk factor for atopic dermatitis — the most common form of eczema. Without adequate filaggrin, corneocytes are misshapen and fragile, natural moisturizing factors are depleted, and the lipid mortar is disorganized. The result is a porous barrier: water escapes far more readily (transepidermal water loss, TEWL), and the skin becomes dry and permeable. Crucially, the cracks admit what healthy skin excludes — house dust mite proteins, pollens, staphylococcal toxins, and irritants penetrate into the living epidermis, where immune sentinels await. Filaggrin deficiency does not cause eczema by itself, but it opens the door through which every trigger walks.
The Th2 immune skew
Once allergens and microbes penetrate the defective barrier, the immune response in atopic dermatitis skews toward the T-helper 2 (Th2) pathway. Dendritic cells in the skin present the intruders to T cells, which release the signature Th2 cytokines: interleukin-4 and interleukin-13, which drive B cells to produce IgE antibodies and further suppress filaggrin production (worsening the barrier defect in a vicious cycle), and interleukin-31, a potent itch cytokine that acts directly on sensory nerve endings. IgE arms mast cells, which degranulate on re-exposure, adding histamine-driven inflammation. In chronic lesions the response broadens to include Th1 and Th22 pathways, thickening the skin (lichenification) — but the initiating engine is Th2, and it is barrier breach that starts it.
Staphylococcus aureus: the opportunist
The skin of most people with atopic dermatitis is heavily colonized by Staphylococcus aureus — often over 90 percent, compared to a small minority of healthy individuals. The defective barrier and Th2-skewed immunity create ideal conditions: antimicrobial peptides that would normally control staph are suppressed by IL-4 and IL-13, and the bacterium's secreted toxins (including superantigens) further stimulate T cells and degrade the barrier. Staph colonization is not merely a consequence of eczema but an amplifier — its toxins intensify inflammation and itch, which is why flares so often coincide with increased bacterial load. The relationship is a second vicious cycle layered atop the first: barrier failure invites staph, and staph worsens barrier failure.
The itch-scratch cycle
Itch is eczema's most maddening symptom, and it is mechanistically distinct from pain. IL-31 and other pruritogens (including histamine and staph toxins) activate dedicated itch-sensing nerve fibers (pruriceptors) in the epidermis. Scratching provides momentary relief because mild pain signals inhibit itch transmission in the spinal cord — the gate control principle applied to itch. But scratching is catastrophic for the barrier: fingernails tear corneocytes, widen the cracks, admit more allergens and staph, and trigger further Th2 inflammation — which produces more IL-31 and more itch. The cycle is self-sustaining: itch causes scratching, scratching causes barrier damage, barrier damage causes inflammation, inflammation causes itch. Breaking any link — restoring the barrier, calming the immune skew, or interrupting the scratch — weakens the whole loop.
This content is educational only and is not medical advice. It explains how body mechanisms work and does not replace professional medical evaluation.
Key points
- The stratum corneum's brick-and-mortar structure depends on filaggrin, ceramides, and natural moisturizing factors.
- Filaggrin loss-of-function mutations are the strongest genetic risk factor, creating a porous, dry barrier.
- Barrier failure admits allergens, irritants, and microbes into the living epidermis, triggering Th2 immunity.
- IL-4/IL-13 drive IgE and suppress filaggrin further; IL-31 directly activates itch nerve fibers.
- Staphylococcus aureus colonizes most eczema skin and amplifies inflammation through toxins.
- The itch-scratch cycle is self-sustaining: scratching damages the barrier, worsening the inflammation that causes itch.
Common misconceptions
✓ Truth: Dryness is a symptom of the underlying barrier defect and Th2 immune skew; moisturizers support the barrier but the disease mechanism involves filaggrin deficiency, immune dysregulation, and staph colonization.
✓ Truth: Atopic dermatitis is a barrier and immune disorder, not an infection — it cannot be transmitted by touch, though the colonizing staph is a normal skin bacterium exploiting the defective barrier.
✓ Truth: Scratching tears the already-defective barrier, admits more triggers, and intensifies the Th2 inflammation driving the itch — momentary relief at the cost of worsening the disease cycle.
✓ Truth: In most cases the direction runs the other way: a defective skin barrier admits food proteins through the skin, which can promote sensitization — the barrier defect is primary, not the diet.
Frequently asked questions
What is filaggrin and why does it matter in eczema?
Filaggrin bundles keratin inside skin cells and breaks down into natural moisturizing factors. Loss-of-function mutations produce a porous, dry barrier that leaks water and admits allergens and microbes — the foundational defect of atopic dermatitis.
Why is eczema so itchy?
The Th2 cytokine IL-31 acts directly on dedicated itch nerve fibers in the skin, joined by histamine from mast cells and toxins from colonizing staph. The itch is a primary immune-neural signal, not just a side effect of dryness.
Why does scratching make eczema worse?
Scratching tears corneocytes and widens barrier cracks, admitting more allergens and bacteria and triggering more Th2 inflammation — which generates more itch signals. It trades seconds of relief for escalation of the whole cycle.
What is the difference between atopic dermatitis and contact dermatitis?
Atopic dermatitis is a chronic barrier-defect plus Th2 immune skew disorder, often with filaggrin mutations. Contact dermatitis is a localized reaction to a specific irritant or allergen touching the skin — different trigger, different mechanism.
Why do people with eczema get so many skin infections?
The defective barrier admits bacteria easily, while Th2 cytokines (IL-4, IL-13) suppress the skin's antimicrobial peptides — a double failure of physical and chemical defense that lets Staphylococcus aureus thrive.